☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Mirati Signs a Non-Exclusive Clinical Collaboration Agreement with Verastem to Evaluate Adagrasib + VS-6766 for KRASG12C-Mutant NS...
November 23, 2021
Regeneron Entered into a License Agreement with Nykode to Develop Vaccines Against Cancer and Infectious Diseases
November 23, 2021
Pfizer and BioNTech Report Results of COVID-19 Vaccine in P-III Trial for the Treatment of COVID-19
November 23, 2021
PharmaShots Interview: ProQR’s Daniel A. de Boer Shares Insight on Sepofarsen for the Treatment of Leber Congenital Amaurosis (LCA...
November 23, 2021
Neurocrine Signs a License Agreement with Sosei Heptares to Develop Novel Muscarinic Receptor Agonists for Schizophrenia and Other...
November 23, 2021
Arrowhead Entered into an Exclusive License Agreement with GSK to Develop and Commercialize ARO-HSD for Nonalcoholic Steatohepatit...
November 23, 2021
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions